Skip to main content

Biopharma Startups

Updated July 2026

Companies in the biopharma sector developing innovative solutions and technologies.

Explore 854 recently funded biopharma companies with verified founder contact information and fundraising data.

Total Companies
854
Total Funding
$801.8M
Avg Funding
$32.1M
Global Reach
7
countries

Top Cities for Biopharma

Bordeaux
San Francisco
London
Nashville
Redwood City
La Habra

Recently Funded Companies

Export
Bordeaux, France

TreeFrog Therapeutics is a stem cell company that will enable millions of patients to access the medical revolution of cell therapies.

$34.0M raised
May 2025

Founder Contacts

30,000+ verified contacts

San Francisco, United States

Reprogram Biosciences is a biotechnology company that develops cancer treatment with cell reprogramming technology.

$5.0M raised
May 2026

Founder Contacts

30,000+ verified contacts

London, United Kingdom

Perceptic develops modular AI software that supports scientific decision-making for biopharma research and external asset evaluation.

$12.0M raised
May 2026

Founder Contacts

30,000+ verified contacts

Nashville, United States

Amytrx Therapeutics is a biopharmaceutical company that advances the next generation of new anti-inflammatory peptide therapies.

$18.0M raised
May 2022

Founder Contacts

30,000+ verified contacts

Redwood City, United States

Retro Biosciences focuses on cellular reprogramming, autophagy, and plasma-inspired therapeutics.

May 2026

Founder Contacts

30,000+ verified contacts

La Habra, United States

Oculogenex is a biopharmaceutical company that specializes in gene therapy for the treatment of retinal disorders.

$1.0M raised
May 2022

Founder Contacts

30,000+ verified contacts

Cincinnati, United States

NeutraNarc is an eco biotechnology company that offers biodegradable drug disposal chemicals and products.

$9.6M raised
May 2025

Founder Contacts

30,000+ verified contacts

Pittsburgh, United States

Krystal Biotech provide significant clinical benefit for patients suffering from rare debilitating disorders..

$160.0M raised
May 2023

Founder Contacts

30,000+ verified contacts

San Diego, United States

cAMPfield Therapeutics is a biotechnology company that specializes on exploration and development activities of therapeutic solutions.

$180.0M raised
May 2026

Founder Contacts

30,000+ verified contacts

Saskatoon, Canada

ZYUS is a biopharmaceutical company that offers patients cannabinoid and other phyto-therapeutic medical solutions.

$505K raised
May 2026

Founder Contacts

30,000+ verified contacts

Salt Lake City, United States

Co-Diagnostics is a molecular diagnostics company that enhances the output of molecular diagnostic tests.

$3.0M raised
May 2026

Founder Contacts

30,000+ verified contacts

New York, United States

Calder Biosciences is a groundbreaking biotechnology and molecular engineering firm developing next generation subunit vaccines

May 2025

Founder Contacts

30,000+ verified contacts

Basel, Switzerland

Encelta T-cell therapy target and eliminate both blood cancers and solid tumors combined with bispecific antibodies.

$1.7M raised
May 2025

Founder Contacts

30,000+ verified contacts

Morrisville, United States

Locus Biosciences develops CRISPR-engineered precision antibacterial platform designed to revolutionize the treatment of bacterial disease.

$35.0M raised
May 2022

Founder Contacts

30,000+ verified contacts

Auckland, New Zealand

Helico is a biopharma company that intends to make plants able to manufacture lifesaving medicine.

$1.3M raised
May 2022

Founder Contacts

30,000+ verified contacts

Gainesville, United States

Kincell Bio collaborates with cell therapy developers by using considerable scientific experience and industry understanding.

$22.0M raised
May 2025

Founder Contacts

30,000+ verified contacts

Solana Beach, United States

ClearPath Vascular is a healthcare company that offers technologies that can be used in neuro and peripheral vascular procedures.

$1.0M raised
May 2025

Founder Contacts

30,000+ verified contacts

Boston, United States

Antares is a biotechnology company focused on developing transformational,medicines targeting validated cancer and other serious diseases.

$177.0M raised
May 2025

Founder Contacts

30,000+ verified contacts

Fort Worth, United States

AyuVis is a start-up biopharmaceutical company, developing a new class of immunotherapies to prevent and treat inflammation and infection.

$2.1M raised
May 2023

Founder Contacts

30,000+ verified contacts

Calgary, Canada

XORTX Therapeutics is a BioPharmaceutical company focused on developing innovative therapies to treat progressive kidney disease

$5.0M raised
May 2026

Founder Contacts

30,000+ verified contacts

Los Angeles, United States

Bionaut Labs revolutionizes the treatment of central nervous system disorders with its precision medicine treatment modality.

$712K raised
May 2024

Founder Contacts

30,000+ verified contacts

Dallas, United States

Lantern Pharma is a clinical stage biopharma company developing precision oncology therapies leveraging A.I., machine learning, and genomics

$4.4M raised
May 2026

Founder Contacts

30,000+ verified contacts

Pacific Palisades, United States

Whitehawk Therapeutics, a clinical-stage oncology therapeutics firm, applies cutting-edge technologies to well-established tumor biology.

$87.5M raised
May 2026

Founder Contacts

30,000+ verified contacts

Charlottesville, United States

Avant Genomics is a biotechnology company that develops automated laboratory solutions for genomic and cancer research.

$3.0M raised
May 2026

Founder Contacts

30,000+ verified contacts

Ulm, Germany

NVision Imaging Technologies develops quantum-based medical imaging technology that enhances the capabilities of standard MRI systems.

$38.0M raised
May 2026

Founder Contacts

30,000+ verified contacts

Showing 226 to 250 of 854 companies

About the Biopharma Startup Ecosystem

The biopharma sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.

Funding Trends in Biopharma

Biopharma companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.

Growth Outlook

The biopharma sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.

Biopharma Funding Breakdown

Here is how funding is distributed among the 854 biopharma companies tracked in the VCBacked database.

Average Funding
$32.1M
Total Funding Tracked
$801.8M
Countries Represented
7

Distribution by Funding Stage

Other25 companies

Top Cities for Biopharma

1.Bordeaux
1 companies$34.0M
2.San Francisco
1 companies$5.0M
3.London
1 companies$12.0M
4.Nashville
1 companies$18.0M
5.Redwood City
1 companiesUndisclosed

Related Industries

Companies in the biopharma sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.

Ready to Connect with Biopharma Startups?

Perfect for: B2B sales teams targeting biopharma companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked